CaMKII inhibitors (Dainippon Sumitomo Pharma)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCaMKII inhibitors (Dainippon Sumitomo Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/Calmodulin dependent protein kinase II inhibitors
TargetsCalcium/Calmodulin dependent protein kinase II
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Chemical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Chemical Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A